Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2041 to 2055 of 7677 results

  1. Transcatheter Tricuspid Valve Replacement

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  2. Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma [ID1441]

    In development [GID-TA10428] Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]

    In development [GID-TA11484] Expected publication date: 26 February 2025

    Technology appraisal guidance
    In development

  4. Pembrolizumab with chemotherapy for treating hormone receptor-positive HER2-negative locally recurrent inoperable or metastatic breast cancer [ID6285]

    Awaiting development [GID-TA11342] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]

    Awaiting development [GID-TA11116] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears TSID8472

      Status ...

    Technology appraisal guidance
    Topic selection

  7. Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers (MTG20)

    Evidence-based recommendations on Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers.

    Medical technologies guidance
    Last updated
    19 May 2021
    View recommendations

    Sections for MTG20

  8. The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters (MTG24)

    Evidence-based recommendations on The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters.

    Medical technologies guidance
    Last updated
    30 May 2019
    View recommendations

    Sections for MTG24

  9. Inavolisib with palbociclib and fulvestrant for treating HR+/HER2-, PIK3CA mutated locally advanced or metastatic breast cancer TS ID 11990

    Awaiting development [GID-TA11519] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. MiraQ for assessing graft flow during coronary artery bypass graft surgery (MTG8)

    Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery.

    Medical technologies guidance
    Last updated
    5 July 2022
    View recommendations

    Sections for MTG8

  11. New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (DG3)

    Evidence-based recommendations on new generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners

    Diagnostics guidance
    Last updated
    6 July 2017
    View recommendations

    Sections for DG3

  12. Overweight and obesity management

    In development [GID-NG10182] Expected publication date: TBC

    NICE guideline
    In development

  13. Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms (MTG10)

    Evidence-based recommendations on the Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms.

    Medical technologies guidance
    Last updated
    9 January 2019
    View recommendations

    Sections for MTG10

  14. Durvalumab for neoadjuvant and adjuvant treatment of muscle-invasive bladder cancer [ID6168]

    Awaiting development [GID-TA11115] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Niraparib with dostarlimab for maintenance treatment of advanced or recurrent endometrial cancer [ID6316]

    Awaiting development [GID-TA11365] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development